GW Pharma to float US shares

GW Pharmaceuticals Plc said it intends to issue $225 million worth of its shares on the US Nasdaq market subject to market conditions and investor appetite.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom